Literature DB >> 12735931

Biochemical definitions of disease activity in acromegaly.

Flavia Lucia Conceição1, Sanne Fisker, Jens Sandahl Christiansen, Jens Astrup, Jørgen Weeke, Jens Otto Lunde Jørgensen.   

Abstract

UNLABELLED: In acromegaly the therapeutic outcome is difficult to assess and depends on the biochemical method. We have ascertained disease activity in 70 acromegalic patients by means of a GH profile (8 hourly samples) and a single IGF-I measurement as compared to a healthy control group. As an estimate of the "stiffness" of the GH profile we calculated the SD/nadir(GH) from the GH profile. In the control group the following upper normal limits were obtained: IGF-I (microg/l) 217; mean GH (microg/l) 2.16; nadir GH (g/l) 0.3. Based on ROC plot analysis a value of 2.0 for the SD/nadir ratio was used as cut-off. This translated into the following surgical cure rates (%): IGF-I 47; mean GH 77; nadir GH 65; SD/nadir 30. Some of the patients post-surgery had elevated IGF-I levels despite "normal" GH levels. Abnormal SD/nadir versus normal IGF-I and vice versa were recorded in many patients post-surgery. IN
CONCLUSION: (1) cure rates of acromegaly depend strongly on the criteria being used and (2) estimates of GH secretion pattern may yield important information about GH status in acromegaly.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12735931     DOI: 10.1016/s1096-6374(03)00009-1

Source DB:  PubMed          Journal:  Growth Horm IGF Res        ISSN: 1096-6374            Impact factor:   2.372


  2 in total

1.  Quantification of day-to-day variability in growth hormone levels in acromegaly.

Authors:  Andrew Kraftson; Ariel Barkan
Journal:  Pituitary       Date:  2010-12       Impact factor: 4.107

2.  Assessment of the magnitude of growth hormone hypersecretion in active acromegaly: reliability of different sampling models.

Authors:  Katica Bajuk Studen; Ariel Barkan
Journal:  J Clin Endocrinol Metab       Date:  2007-11-20       Impact factor: 5.958

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.